To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

NCT01987427 ·Status: COMPLETED ·Phase: PHASE4

Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

NCT03041792 ·Status: COMPLETED ·Phase: PHASE1

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight

NCT06824051 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Zenoctil in Reducing Body Weight

NCT01423617 ·Status: COMPLETED ·Phase: PHASE3

BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus

NCT00603291 ·Status: COMPLETED ·Phase: PHASE3

Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD

NCT06564584 ·Status: RECRUITING ·Phase: PHASE2

Effect of Orlistat in Body Composition

NCT00752726 ·Status: COMPLETED ·Phase: PHASE4

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

NCT06584916 ·Status: COMPLETED ·Phase: PHASE3

A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

NCT06313528 ·Status: COMPLETED ·Phase: PHASE1

BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

NCT00603902 ·Status: COMPLETED ·Phase: PHASE3

BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management

NCT00395135 ·Status: COMPLETED ·Phase: PHASE3

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

NCT06801015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans

NCT02718950 ·Status: UNKNOWN ·Phase: PHASE3

A Study of LY3537021 in Healthy Participants

NCT05444569 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome

NCT03692806 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

NCT06410924 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects

NCT02568319 ·Status: COMPLETED ·Phase: PHASE2

Predictors of Lorcaserin-Induced Weight Loss

NCT03353220 ·Status: TERMINATED ·Phase: PHASE4

Dose Ranging and Dose Frequency of LIPO-102

NCT00918814 ·Status: COMPLETED ·Phase: PHASE2

Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic

NCT03552107 ·Status: COMPLETED

Efficacy of Olibra: A 12 Week Controlled Trial

NCT01416051 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

NCT00330525 ·Status: COMPLETED ·Phase: PHASE2

A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity

NCT01180465 ·Status: COMPLETED ·Phase: PHASE2

Study of Fat Malabsorption by Lipiblock Versus Xenical

NCT01170806 ·Status: COMPLETED ·Phase: NA